Similar articles

• Precursor lesions of prostate cancer.

  Chrisofos M, Papatsoris AG, Lazaris A, Deliveliotis C. Chrisofos M, et al. Crit Rev Clin Lab Sci. 2007;44(3):243-70. doi: 10.1080/10408360601177236. Crit Rev Clin Lab Sci. 2007. PMID: 17453919 Review.
• Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective.

  Vis AN, Van Der Kwast TH. Vis AN, et al. BJU Int. 2001 Jul;88(2):147-57. doi: 10.1046/j.1464-410x.2001.02295.x. BJU Int. 2001. PMID: 11446873 Review. No abstract available.
• [Clinicopathological features of prostate cancer].

  Nakano H, Watanabe M, Shiraishi T. Nakano H, et al. Nihon Rinsho. 2002 Dec;60 Suppl 11:88-94. Nihon Rinsho. 2002. PMID: 12599551 Review. Japanese. No abstract available.
• [Management in case of isolated precancerous lesions of the prostate (HG-PIN) discovered with biopsy].

  Ruffion A, Villers A, Molinié V. Ruffion A, et al. Prog Urol. 2003 Nov;13(5 Suppl 2):1268-71. Prog Urol. 2003. PMID: 15816403 Review. French. No abstract available.
• Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.

  Nasir A, Copeland J, Gillespie JW, Chughtai OR, Andrawis R, Kaiser HE, Manyak MJ. Nasir A, et al. In Vivo. 2002 Nov-Dec;16(6):557-66. In Vivo. 2002. PMID: 12494901 Review.